Minutes of Advisory Committee on the MSBT 19th meeting, re outsourcing labile blood components, progress on leucodepletion, supply of blood products from non-UK plasma, exclusion of donors who have received nvCJD implicated blood, RCOG guidelines on Anti-D, HCV RNA NAT testing, HCV lookback and national register, testing for hepatitis B core antibody, virally inactivated FPP, revision of MSBT guidance, future of MSBT, revision of national agreement on blood prices, new viruses